As of September 2023 it is on the FDA Category 2 list of bulk drug substances that may not be compounded, and a PCAC review is scheduled for July 2026 under the name Emideltide
Glutathione has been found to prevent the signs for aging, and to protect against cancer, heart disease, and dementia
Within its role as the bodys most important antioxidant, Glutathione is capable of preventing damage to important cellular components caused by reactive oxygen species (such as free radicals, peroxides, lipid peroxides), xenobiotics, and heavy metals Glutathione also plays important roles in nutrient metabolism, and regulation of cellular events including
Preclinical studies suggest therapeutic potential for strategies targeting EMT transcription factors, signaling pathways, and combination approaches
Subcutaneous placement sits shallow and matches frequent schedules
Medical aesthetic patients need to find their treatment at facilities which maintain proper medical standards